Pre-Surgery Precautions Because GLP-1 medications slow down gastric emptying, they can increase the risk of aspiration during general anesthesia
We must stay grounded
We need to get off this roller coaster, where access and affordability are pitted against each other, and move toward a financially sustainable treatment approach that actually enables progress on chronic disease
GLP-1s and related drugs can lead to health benefits beyond weight loss
Christen S, Redeuil K, Goulet L, Giner MP, Breton I, Rota R, et al
A meta-analysis of 6 studies 13,20,30,32,33,35 which attempted to estimate overall effect size of the changes from baseline in % FMD following GLP-1-based therapies could not find any significant difference between baseline and end-of-treatment samples (mean change from baseline was 0.83 [1.06, 2.73] %